Trace amine-associated receptor
Trace amine-associated receptors (TAARs), sometimes referred to as trace amine receptors (TAs or TARs), are a class of
Animal TAAR complement
The following is a list of the TAARs contained in selected animal genomes:[10][11]
- Human – 6 genes (TAAR1, TAAR2, TAAR5, TAAR6, TAAR8, TAAR9) and 3 pseudogenes (TAAR3, TAAR4P, TAAR7P)[12]
- Chimpanzee– 3 genes and 6 pseudogenes
- Mouse – 15 genes and 1 pseudogene
- Rat – 17 genes and 2 pseudogenes
- Zebrafish – 112 genes and 4 pseudogenes
- Frog – 3 genes and 0 pseudogenes
- Medaka– 25 genes and 1 pseudogenes
- Stickleback – 25 genes and 1 pseudogenes
Human trace amine-associated receptors
Six human trace amine-associated receptors (hTAARs) – hTAAR1, hTAAR2, hTAAR5, hTAAR6, hTAAR8, and hTAAR9 – have been identified and partially characterized. The table below contains summary information from literature reviews, pharmacology databases, and supplementary primary research articles on the expression profiles, signal transduction mechanisms, ligands, and physiological functions of these receptors.
TAAR subtype |
Prior names |
Signal transduction |
Expression profile |
Known or putative function in humans[note 1] | Known ligands | Sources |
---|---|---|---|---|---|---|
hTAAR1 | TA1 TAR1 |
β-arrestin 2
|
leukocytes, elsewhere[note 2]
|
• blood glucose • Regulation of satiety & body weight |
• | [3][13] [15][16] |
hTAAR2 [note 3] |
GPR58 | Golf, other G protein coupling unknown[note 4] | CNS: brain (restricted) testes , leukocytes
|
• Periphery: |
[9][13] [15][16] [17][18] | |
TAAR3 | GPR57 | N/A | N/A | Pseudogene in humans – N/A | N/A | [12][13] [15] |
TAAR4 | TA2 | N/A | N/A | Pseudogene in humans – N/A | N/A | [12][13] [15] |
hTAAR5 | PNR | Gs, Golf, Gq, G12/13 |
CNS: brain (restricted), spinal cord Periphery: olfactory epithelium, intestines, testes, leukocytes |
• Olfaction: chemoreceptor for volatile & foul odorants[note 6] | • Agonists: 3-iodothyronamine
|
[9][13] [15][20] [21][22] [23] |
hTAAR6 | TA4 TAR4 |
Golf, other G protein coupling unknown | CNS: brain Periphery: olfactory epithelium, intestines, testes, leukocytes, kidneys |
• Olfaction: chemoreceptor for volatile odorants[note 6] | • Agonists: putrescine and cadaverine[24] | [9][13] [15][25] |
TAAR7 | – | N/A | N/A | Pseudogene in humans – N/A | N/A | [9][13] [15] |
hTAAR8 | TA5 GPR102 |
Gi/o
|
CNS: brain Periphery: olfactory epithelium, |
• Olfaction: chemoreceptor for volatile odorants[note 6] | • Agonists: putrescine and cadaverine[24] | [9][13] [15][27] |
hTAAR9 [note 7] |
TA3 TAR3 |
Golf, other G protein coupling unknown | CNS: spinal cord Periphery: olfactory epithelium, intestines, leukocytes, pituitary gland, skeletal muscle, spleen |
• Olfaction: chemoreceptor for volatile odorants[note 6] | • Agonist: N-Methyl piperidine (CAS: 626-67-5) [28] | [9][13] [15][29] |
|
Disease links and clinical significance
Ulotaront / SEP 363856 is a TAAR1 agonist in phase 3 clinical trials for schizophrenia and earlier trials for Parkinson's Disease psychosis. The medicine has obtained Breakthrough designation from the US FDA.[30][31][32]
This section needs expansion with: coverage of relevant material from this review[13]. You can help by adding to it. (March 2018) |
See also
- Olfactory receptor
- Odorant
- Pheromone
- Pheromone receptor
- Psychostimulant
- Thyronamine
- Trace amine
References
- PMID 11459929.
- PMID 11723224.
- ^ PMID 21073468.
- PMID 26093041.
- ^ S2CID 2389946.
- PMID 15860375.
- PMID 16451074.
- PMID 17888514.
- ^ PMID 25616211.
Roles for another receptor are supported by TAAR5-independent trimethylamine anosmias in humans [32]. ... Several TAARs detect volatile and aversive amines, but the olfactory system is capable of discarding ligand-based or function-based constraints on TAAR evolution. Particular TAARs have mutated to recognize new ligands, with almost an entire teleost clade losing the canonical amine-recognition motif. Furthermore, while some TAARs detect aversive odors, TAAR-mediated behaviors can vary across species. ... The ability of particular TAARs to mediate aversion and attraction behavior provides an exciting opportunity for mechanistic unraveling of odor valence encoding.
Figure 2: Table of ligands, expression patterns, and species-specific behavioral responses for each TAAR - PMID 19237578.
- PMID 19325074.
- ^ PMID 23686350.
TAAR2 and TAAR9 Two of the trace amine receptors are inactivated in a portion of the human population. There is a polymorphism in TAAR2 (rs8192646) producing a premature stop codon at amino acid 168 in 10–15% of Asians. TAAR9 (formerly TRAR3) appears to be functional in most individuals but has a polymorphic premature stop codon at amino acid 61 (rs2842899) with an allele frequency of 10–30% in different populations (Vanti et al., 2003). TAAR3 (formerly GPR57) and TAAR4 (current gene symbol, TAAR4P) are thought to be pseudogenes in man though functional in rodents (Lindemann et al., 2005).
- ^ PMID 28723415.
- ^ S2CID 2864195.
- ^ a b c d e f g h i j k "Trace amine receptor: Introduction". International Union of Basic and Clinical Pharmacology. Retrieved 15 February 2014.
Importantly, three ligands identified activating mouse Taars are natural components of mouse urine, a major source of social cues in rodents. Mouse Taar4 recognizes β-phenylethylamine, a compound whose elevation in urine is correlated with increases in stress and stress responses in both rodents and humans. Both mouse Taar3 and Taar5 detect compounds (isoamylamine and trimethylamine, respectively) that are enriched in male versus female mouse urine. Isoamylamine in male urine is reported to act as a pheromone, accelerating puberty onset in female mice [34]. The authors suggest the Taar family has a chemosensory function that is distinct from odorant receptors with a role associated with the detection of social cues. ... The evolutionary pattern of the TAAR gene family is characterized by lineage-specific phylogenetic clustering [26,30,35]. These characteristics are very similar to those observed in the olfactory GPCRs and vomeronasal (V1R, V2R) GPCR gene families.
- ^ PMID 23315425.
- ^ a b "TAAR2". International Union of Basic and Clinical Pharmacology. Retrieved 15 May 2018.
Primary Transduction Mechanisms
Comments: TAAR2 is found to be coexpressed with Gα proteins. However, the transduction pathway of TAAR2 is yet to be determined. - ^ PMID 27424325.
- ^ PMID 26684881.
While mice produce gender-specific amounts of urinary TMA levels and were attracted by TMA, this odor is repellent to rats and aversive to humans [19], indicating that there must be species-specific functions. ... Furthermore, a homozygous knockout of murine TAAR5 abolished the attraction behavior to TMA [19]. Thus, it is concluded that TAAR5 itself is sufficient to mediate a behavioral response at least in mice. ... Whether the TAAR5 activation by TMA elicits specific behavioral output like avoidance behavior in humans still needs to be examined.
- ISBN 978-3540389163.
- PMID 23393561.
- PMID 23407976.
We show that [human TAAR5] responds to the tertiary amine N,N-dimethylethylamine and to a lesser extent to trimethylamine, a structurally related agonist for mouse and rat TAAR5 (Liberles and Buck, 2006; Staubert et al., 2010; Ferrero et al., 2012).
- PMID 25706283.
- ^ PMID 29324768.
- ^ "TAAR6". International Union of Basic and Clinical Pharmacology. Retrieved 15 May 2018.
Tissue Distribution
Kidney, amygdala, hippocampus; Species: Human; Technique: RT-PCR ...
Human brain tissues (with the level of expression descending from hippocampus, substantia nigra, amygdala, frontal cortex to basal ganglia), human fetal liver. Not detected in the cerebellum or placenta.; Species: Human; Technique: RT-PCR - PMID 35053262.
- PMID 25391046.
- PMID 25616211.
- ^ "TAAR9". International Union of Basic and Clinical Pharmacology. Retrieved 15 May 2018.
Tissue Distribution Comments ... No expression of TAAR9 was detected by RT-PCR in the Grueneberg ganglion [2]. TAAR9 expression was not detected by Northern blot analysis in thalamus, amygdala, midbrain, hippocampus, putamen, caudate, frontal cortex, pons, prostate, stomach, heart, bladder, small intestine, colon or uterus [4].
- PMID 35047111.
- ^ "Sunovion: creating therapies to help transform people's lives". www.sunovion.com. Retrieved 4 June 2022.
- ^ "Sunovion and PsychoGenics Announce that SEP-363856 Has Received FDA Breakthrough Therapy Designation for the Treatment of People with Schizophrenia". news.sunovion.com. Retrieved 4 June 2022.
External links
- "Trace Amine Receptors". IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology.